Moreover, the results of ROC analysis showed that either IL-1β or TGF-β could distinguish BE patients from healthy controls.<h4>Conclusion</h4>IL-1β and TGF-β levels were upregulated in BE and might function as potential biomarkers or therapeutic targets for BE patients. The gene discussed is IL1B; the disease is Barrett esophagus.